Literature DB >> 8866554

Responses of leptin to short-term fasting and refeeding in humans: a link with ketogenesis but not ketones themselves.

J W Kolaczynski1, R V Considine, J Ohannesian, C Marco, I Opentanova, M R Nyce, M Myint, J F Caro.   

Abstract

We investigated the response of leptin to short-term fasting and refeeding in humans. A mild decline in subcutaneous adipocyte ob gene mRNA and a marked fall in serum leptin were observed after 36 and 60 h of fasting. The dynamics of the leptin decline and rise were further substantiated in a 6-day study consisting of a 36-h baseline period, followed by 36-h fast, and a subsequent refeeding with normal diet. Leptin began a steady decline from the baseline values after 12 h of fasting, reaching a nadir at 36 h. The subsequent restoration of normal food intake was associated with a prompt leptin rise and a return to baseline values 24 h later. When responses of leptin to fasting and refeeding were compared with that of glucose, insulin, fatty acids, and ketones, a reverse relationship between leptin and beta-OH-butyrate was found. Consequently, we tested whether the reciprocal responses represented a causal relationship between leptin and beta-OH-butyrate. Small amounts of infused glucose equal to the estimated contribution of gluconeogenesis, which was sufficient to prevent rise in ketogenesis, also prevented a fall in leptin. The infusion of beta-OH-butyrate to produce hyperketonemia of the same magnitude as after a 36-h fast had no effect on leptin. The study indicates that one of the adaptive physiological responses to fasting is a fall in serum leptin. Although the mediator that brings about this effect remains unknown, it appears to be neither insulin nor ketones.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8866554     DOI: 10.2337/diab.45.11.1511

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  56 in total

Review 1.  Regulation of leptin production.

Authors:  R V Considine
Journal:  Rev Endocr Metab Disord       Date:  2001-10       Impact factor: 6.514

2.  Effects of prolonged hyperinsulinemia on serum leptin in normal human subjects.

Authors:  G Boden; X Chen; J W Kolaczynski; M Polansky
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

Review 3.  Plasma leptin and exercise: recent findings.

Authors:  Matthew W Hulver; Joseph A Houmard
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

4.  Decreased serum leptin levels during prolonged high altitude exposure.

Authors:  Marco Zaccaria; Andrea Ermolao; Piero Bonvicini; Giuseppe Travain; Maurizio Varnier
Journal:  Eur J Appl Physiol       Date:  2004-04-09       Impact factor: 3.078

5.  Rapid inhibition of neurons in the dorsal motor nucleus of the vagus by leptin.

Authors:  K W Williams; A Zsombok; B N Smith
Journal:  Endocrinology       Date:  2006-12-28       Impact factor: 4.736

Review 6.  Central dysregulations in the control of energy homeostasis and endocrine alterations in anorexia and bulimia nervosa.

Authors:  A Torsello; F Brambilla; L Tamiazzo; I Bulgarelli; D Rapetti; E Bresciani; V Locatelli
Journal:  J Endocrinol Invest       Date:  2007-12       Impact factor: 4.256

7.  Leptin signaling and Alzheimer's disease.

Authors:  Gurdeep Marwarha; Othman Ghribi
Journal:  Am J Neurodegener Dis       Date:  2012-11-18

8.  Rapid inhibition of neural excitability in the nucleus tractus solitarii by leptin: implications for ingestive behaviour.

Authors:  K W Williams; B N Smith
Journal:  J Physiol       Date:  2006-03-31       Impact factor: 5.182

9.  Effects of seafood consumption and weight loss on fasting leptin and ghrelin concentrations in overweight and obese European young adults.

Authors:  Alfons Ramel; Dolores Parra; J Alfredo Martinéz; Mairead Kiely; Inga Thorsdottir
Journal:  Eur J Nutr       Date:  2009-01-13       Impact factor: 5.614

Review 10.  Leptin and obesity in humans.

Authors:  R V Considine
Journal:  Eat Weight Disord       Date:  1997-06       Impact factor: 4.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.